AbbVie and Neomorph, announced a collaboration and option-to-license agreement to develop novel molecular glue degraders for multiple targets across oncology and immunology.
Molecular glue degraders...
VALID, a Techbio startup dedicated to reshaping drug discovery with complex human induced pluripotent stem cell (iPSC) co-culture models that deliver increased predictive validity,...
Eli Lilly and Company and Scorpion Therapeutics, Inc., a private biotechnology company developing small molecule precision oncology therapies, announced a definitive agreement for Lilly...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Charles River Laboratories International, Inc. and Akron Bio, a leading supplier of critical materials and services for advanced therapies, announced the integration of Akron’s...
